SCHEMBL6164754

SCHEMBL6164754

CC1(C)CCC(=O)c2c(-c3ccco3)nn(CC(F)(F)F)c21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EEF2K O00418 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.32
TDP1 Q9NUW8 2/20 0.32
HSF1 Q00613 1/20 0.31
ALDH1A1 P00352 4/20 0.31
KDM4E B2RXH2 2/20 0.31
HPGD P15428 2/20 0.31
HSD17B10 Q99714 2/20 0.31
MEN1 O00255 2/20 0.30
ALOX15 P16050 2/20 0.30
KMT2A Q03164 2/20 0.30
MERTK Q12866 1/20 0.30
POLQ O75417 2/20 0.30
POLB P06746 2/20 0.30
ADORA2A P29274 1/20 0.30
USP2 O75604 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
THRB P10828 1/20 0.30
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164080 0.84
SCHEMBL6165367 0.83 EEF2K (0.32) EEF2KL3MBTL1TDP1HSF1ALDH1A1
SCHEMBL6165500 0.82 PTGS2 (0.38) ALDH1A1HSD17B10MEN1ALOX15KMT2A
SCHEMBL6165166 0.80 USP19 (0.33) ALDH1A1KDM4EKMT2AMERTKPOLQ
SCHEMBL6167609 0.79 CDC7 (0.37) ALDH1A1
SCHEMBL6161815 0.79 ADORA1 (0.38) L3MBTL1HSF1ALDH1A1KDM4EHPGD
SCHEMBL6163427 0.79 POLL (0.34) ALDH1A1KDM4EHPGDPOLQMAPT
SCHEMBL6167324 0.78 BRD4 (0.38) ALDH1A1HPGDHSD17B10MEN1KMT2A
SCHEMBL6166169 0.77 METAP2 (0.34) POLQ
SCHEMBL6165739 0.76 AURKA (0.31) KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed